Cargando…
Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in CHRNE gene
Congenital myasthenic syndromes (CMS) are rare and heterogeneous genetic diseases characterized by compromised neuromuscular transmission and clinical features of fatigable weakness; age at onset, presenting symptoms, distribution of weakness, and response to treatment differ depending on the underl...
Autores principales: | Ardissone, Anna, Moroni, Isabella, Bernasconi, Pia, Brugnoni, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SRL
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479107/ https://www.ncbi.nlm.nih.gov/pubmed/28690392 |
Ejemplares similares
-
CHRNE compound heterozygous mutations in congenital myasthenic syndrome: A case report
por: Yang, Kunfang, et al.
Publicado: (2018) -
A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome
por: Chan, Cassie, et al.
Publicado: (2023) -
Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports
por: Huang, Kun, et al.
Publicado: (2021) -
A case report of congenital myasthenic syndrome caused by a mutation in theCHRNE genein the Iranian population
por: FARJAMI, Zahra, et al.
Publicado: (2020) -
Homozygous Duplication in the CHRNE in a Family with Congenital Myasthenic Syndrome 4C: 18-Year Follow Up
por: Almatrafi, Ahmad M., et al.
Publicado: (2023)